- Home
- ALNT vs HRMY Comparison
ALNT vs HRMY Comparison
Compare ALNT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALNT | HRMY |
|---|---|---|
| Founded | 1962 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALNT | HRMY |
|---|---|---|
| Price | $97.97 | $34.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $64.50 | $44.11 |
| AVG Volume (30 Days) | 255.4K | ★ 756.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | ★ 67.09 | 7.97 |
| EPS | 0.32 | ★ 0.55 |
| Revenue | $554,478,000.00 | ★ $868,453,000.00 |
| Revenue This Year | $7.53 | $19.75 |
| Revenue Next Year | $6.64 | $12.88 |
| P/E Ratio | $300.09 | ★ $62.11 |
| Revenue Growth | 4.62 | ★ 21.51 |
| 52 Week Low | $35.20 | $25.52 |
| 52 Week High | $100.01 | $40.87 |
Technical Indicators
Market Signals| Indicator | ALNT | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 69.02 | 61.21 |
| Support Level | $56.85 | $25.92 |
| Resistance Level | N/A | $35.47 |
| Average True Range (ATR) | 5.80 | 1.05 |
| MACD | 0.44 | -0.01 |
| Stochastic Oscillator | 77.28 | 64.81 |
Price Performance
Historical ComparisonAbout ALNT Allient Inc.
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty controlled motion components and systems. The firm mainly caters to the Industrial, Vehicle, Aerospace & Defense, and Medical sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.